Follow
Laura Kragie, M.D.
Laura Kragie, M.D.
BioMedWorks LLC
Verified email at biomedworks.com - Homepage
Title
Cited by
Cited by
Year
Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers
SE Lukas, M Sholar, LH Lundahl, X Lamas, E Kouri, JD Wines, L Kragie, ...
Psychopharmacology 125 (4), 346-354, 1996
2921996
Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects
RE Steinert, B Poller, MC Castelli, J Drewe, C Beglinger
The American journal of clinical nutrition 92 (4), 810-817, 2010
1062010
Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects
RE Steinert, B Poller, MC Castelli, J Drewe, C Beglinger
The American journal of clinical nutrition 92 (4), 810-817, 2010
1062010
Orally administered glucagon‐like peptide‐1 affects glucose homeostasis following an oral glucose tolerance test in healthy male subjects
RE Steinert, B Poller, MC Castelli, K Friedman, AR Huber, J Drewe, ...
Clinical Pharmacology & Therapeutics 86 (6), 644-650, 2009
692009
Assessing pregnancy risks of azole antifungals using a high throughput aromatase inhibition assay
L Kragie, SD Turner, CJ Patten, CL Crespi, DM Stresser
Endocrine research 28 (3), 129-140, 2002
522002
Aromatase in primate pregnancy: a review
L Kragie
Endocrine research 28 (3), 121-128, 2002
492002
Membrane iodothyronine transporters part I: review of physiology
L Kragie
Endocrine Research 20 (4), 319-341, 1994
471994
Benzodiazepines inhibit temperature-dependent L-[125I] triiodothyronine accumulation into human liver, human neuroblast, and rat pituitary cell lines.
L Kragie, D Doyle
Endocrinology 130 (3), 1211-1216, 1992
351992
Stoichiometry and apparent dissociation constant of the calcium-arsenazo III reaction under physiological conditions
Z Ahmed, L Kragie, JA Connor
Biophysical journal 32 (3), 907-920, 1980
351980
Composition and method of alleviating adverse side effects and/or enhancing efficacy of agents that inhibit aromatase
L Kragie
US Patent App. 10/474,838, 2004
342004
Membrane iodothyronine transporters part II: review of protein biochemistry
L Kragie
Endocrine research 22 (2), 95-119, 1996
231996
Neuropsychiatric implications of thyroid hormone and benzodiazepine interactions
L Kragie
Endocrine research 19 (1), 1-32, 1993
151993
Computer-assisted molecular modeling of benzodiazepine and thyromimetic inhibitors of the HepG2 iodothyronine membrane transporter.
L Kragie, ML Forrester, V Cody, M McCourt
Molecular Endocrinology 8 (3), 382-391, 1994
131994
Altered peripheral benzodiazepine receptor binding in cardiac and liver tissues from thyroidectomized rats
L Kragie, R Smiehorowski
Life sciences 55 (24), 1911-1918, 1994
131994
Rat cardiac calcium channels and their relationships with β-adrenergic and muscarinic receptors in hypothyroidism
L Kragie, YW Kwon, R Smiehorowski
Endocrine research 19 (1), 57-71, 1993
111993
Measures of skeletal muscle calcium channels and acetylcholine receptors in thyroidectomized rats
L Kragie, R Smiehorowski
Endocrine research 19 (2-3), 207-219, 1993
101993
Method of treating vitamin B12 deficiency
C Castelli, L Kragie
US Patent 8,557,792, 2013
92013
Theophylline—an alternative therapy for bradyarrhythmia in the elderly
L Kragie, B Sekovski
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 12 (4 …, 1992
91992
Method of treating vitamin B12 deficiency
C Castelli, L Kragie
US Patent 8,022,048, 2011
52011
Acetylcholinesterase activity in fast-twitch skeletal muscle from thyroidectomized rats
L Kragie, ME Stock
Endocrine research 20 (1), 47-57, 1994
51994
The system can't perform the operation now. Try again later.
Articles 1–20